Role of cancer antigen-125 from pleural & ascitic fluid samples in non malignant conditions

Indian Journal of Medical Research

Volumn 125, Issue 1, 2007, Pages 25-30

  Kalantri, Yatiraj ^a   Naik, Girish ^a   Joshi, S P ^a   Jain, Ajay ^a   Phatak, Satish ^a   Chavan, Rajesh ^a   Hemvani, Nanda ^a   Chitnis, D S ^a  

^a CHOITHRAM HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

Cirrhosis; Exudate; Hepatitis; Peritonitis; Pleuritis; Pyogenic; Transudate; Tubercular

Indexed keywords

CA 125 ANTIGEN; TUBERCULOSTATIC AGENT;

ARTICLE; ASCITES; ASCITES FLUID; BACTERIAL PERITONITIS; BLOOD SAMPLING; CARDIOMEGALY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS; HUMAN; LIVER CIRRHOSIS; LUNG TUBERCULOSIS; MALE; PERITONEUM; PERITONITIS; PLEURA EFFUSION; PLEURA FLUID; TUBERCULOUS PLEURISY;

ASCITIC FLUID; CA-125 ANTIGEN; FEMALE; HUMANS; MALE; PLEURAL EFFUSION;

EID: 33947171566     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Einhorn N, Sjovall K, Knapp RC, Hall P, Soully RE, Bast RC Jr, et al. Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet Gynecol 1992; 80: 14-8.
2. Bast RC Jr. Status of tumor markers in ovarian cancer screening. J Clin Oncol 2003; 21: 200-5.
3. Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of monoclonal antibody with human ovarian carcinomas. J Clin Invest 1981; 68: 1331-7.
4. Gadducci A, Ferdeghini M, Prontera C, Moretti L, Mariani G, Bianchi R, et al. The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis. Gynecol Oncol 1992; 44: 147-4.
5. Gadducci A, Ferdeghini M, Rispoli G, Pontera C, Bianchi R, Fioretti P. Comparison of tumor-associated trypsin inhibitor (TATI) with CA 125 as a marker for diagnosis and monitoring of epithelial ovarian cancer. Scand J Clin Lab Invest 1991; 51: 19-24.
6. Nistal de Paz F, Herrero-Fernandez B, Perez-Simon R, Fernandez-Perez E, Nistal de Paz C, Ortoll Battle P, et al. Pelvic-peritoneal tuberculosis simulating ovarian carcinoma: report of three cases with elevation of the CA 125. Am J Gastroenterol 1996; 91: 1660-1.
7. Kabawat SE, Bast RC Jr, Bhan AK, Welch W, Knapp RC, Colvin RB. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol 1983; 2: 275-85.
8. Vasilev SA, Schlaerth JB, Campeau J, Morrow CP. Serum CA 125 levels in preoperative evaluation of pelvic masses. Obstet Gynecol 1988; 71: 751-6.
9. Finkler NJ. Clinical utility of CA 125 in preoperative diagnosis of patients with pelvic masses. Eur J Obstet Gynecol Reprod Biol 1993; 49: 105-7.
10. Jacobs IJ, Rivera H, Oram DH, Bast RC Jr. Differential diagnosis of ovarian cancer with tumour markers CA 125, CA 15-3 and TAG 72-3. Br J Obstet Gynecol 1993; 100: 1120-4.
11. Silberstein LB, Rosenthal AN, Coppack SW, Noonan K, Jacobs IJ. Ascites and a raised serum Ca 125- confusing combination. J R Soc Med 2001; 94: 581-2.
12. Rubin J, Rockey DC. Cirrhotic ascites. Ovarian carcinoma and CA125. South Med J 1999; 92: 248-50.
13. Rustin GJ, Marples M, Nelstrop AE, Mahmoudi M, Meyer T. Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels. J Clin Oncol 2001; 19: 4054-7.
14. Rustin GJS, Timmers P, Nelstrop A, Shreeves G, Bentzen SM, Baron B, et al. Comparison of CA-125 and standard definitions of progression of ovarian cancer in the intergroup trial of cisplatin and paclitaxel versus cisplatin and cyclophosphamide. J Clin Oncol 2006; 24: 45-51.
15. Santillan A, Garg R, Zahurak ML, Gardner GJ, Giuntoli RL, Armstrong DK, et al. Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range. J Clin Oncol 2005; 23: 9338-43.
16. Crawford SM, Peace J. Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary? Ann Oncol 2005; 16: 47-50.
17. Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol 1990; 97: 922-9.
18. Buamah P. Benign conditions associated with raised serum CA-125 concentration. J Surg Oncol 2000; 75: 264-5.
19. Giusti G. Adenosine deaminase. In: Bergmeyer HU, editors. Methods of enzymatic analysis. New York: Academic Press; 1974 p. 1092-9.
20. Uzunkoy A, Harma M, Harma M. Diagnosis of abdominal tuberculosis: Experience from 11 cases and review of the literature. World J Gastroenterol 2004; 10: 3647-9.
21. Mahdavi A, Malviya VK, Herschman BR. Peritoneal tuberculosis disguised as ovarian cancer: an emerging clinical challenge. Gynaecol Oncol 2002; 84: 167-70.
22. Molina R, Fitella X, Bruix J, Mengual P, Bosch J, Calvet X, et al. Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases. Clin Chem 1991; 37: 1379-83.
23. Bilgin T, Karabay A, Dolar E, Develioglu OH. Peritoneal tuberculosis with pelvic abdominal mass, ascites and elevated CA 125 mimicking advanced ovarian carcinoma: a series of 10 cases. Int J Gynecol Cancer 2001; 11: 290-4.
24. Mass MR, Comert B, Saglamkaya U, Yamanel L, Kuzhan O, Ateskan U, et al. CA-125; a new marker for diagnosis and follow-up of patients with tuberculous peritonitis. Dig Liver Dis 2000; 32: 595-7.
25. Simsek H, Savas MC, Kadayifci A, Tatar G. Elevated serum CA125 concentration in patients with tuberculous peritinoitis: a case control study. Am J Gastroenterol 1997; 92: 1174-6.
26. Hirose T, Ohta S, Sato I, Matsuda M, Aria T, Katsura T, et al. Tuberculous pleuro-peritonitis showing increased levels of CA125. Nihon Kyobu Shikkan Gakkai Zasshi 1997; 35: 196-200.
27. Hussain SF, Grayez J, Grigorian A, Green JT. Massive pleural effusion & marked increase of CA-125. Postgrad Med J 2004; 80: 300-1.
28. Younossian AB, Rochat T, Favre L, Janssens JP. Ascites and highly elevated CA-125 levels in a case of peritoneal tuberculosis. Scand J Infect Dis 2006; 38: 216-8.
29. Corapcioglu F, Guvenc BH, Sarper N, Aydogan A, Akansel A, Akansel G, et al. Peritoneal tuberculosis with elevated serum CA125 level mimicking advanced ovarian carcinoma in an adolescent. Turk J Pediatr 2006; 48: 69-72.
30. Cakir M, Dilber E, Yaris N, Mungan I, Okten A. A case of tuberculous peritonitis with elevated CA 125. Turk J Pediatr 2005; 47: 100-2.